Status:
COMPLETED
Safe Infusion Device in Reducing Occupational Exposure of Nurses
Lead Sponsor:
Institut de Cancérologie de la Loire
Collaborating Sponsors:
Centre Hospitalier Lyon Sud
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Monocentric comparative before / after study to evaluate the efficacy of Safe Infusion Devices (SIDs) in reducing drug exposure to nurses compared to usual perfusion practices.
Detailed Description
Despite the decreasing of environmental contamination throughout the anticancer drug circuit, the administration of chemotherapies remains at risk of occupational exposure for nurses. Many medical dev...
Eligibility Criteria
Inclusion
- Protocols which contained at least one of the 10 drugs of the dosing assay
- Protocols with at least one disconnection step.
- Given the large number of eligible protocols, we favored those with the most concentrated products (CPM, PMX) to maximize the chance of detecting contamination and also to extend inclusions over a longer period.
Exclusion
- \- Drugs administrated with syringes (intravenously or subcutaneously) were not included because of the absence of impact of the SIDs on these modalities of administration.
Key Trial Info
Start Date :
December 12 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 8 2018
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04102332
Start Date
December 12 2017
End Date
October 8 2018
Last Update
September 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Cancérologie Lucien Neuwirth
Saint-Priest-en-Jarez, France, 42270